Ruliang Xu

Author PubWeight™ 41.77‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am J Physiol Gastrointest Liver Physiol 2005 4.28
2 Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 2007 3.99
3 Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology 2006 2.78
4 The myeloid differentiation factor 88 (MyD88) is required for CD4+ T cell effector function in a murine model of inflammatory bowel disease. J Immunol 2008 1.75
5 Comparative usage of herpesvirus entry mediator A and nectin-1 by laboratory strains and clinical isolates of herpes simplex virus. Virology 2004 1.73
6 GPR15-mediated homing controls immune homeostasis in the large intestine mucosa. Science 2013 1.58
7 Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors. Inflamm Bowel Dis 2009 1.53
8 De novo hepatocellular carcinoma occurring in a transplanted liver: case report and review of the literature. Dig Dis Sci 2006 1.45
9 A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. Am J Physiol Gastrointest Liver Physiol 2009 1.39
10 Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injury. Lab Invest 2010 1.23
11 Molecular genetics of hepatocellular neoplasia. Am J Transl Res 2010 1.16
12 An update on the molecular genetics of hepatocellular carcinoma. Semin Liver Dis 2004 1.15
13 Molecular classification of soft tissue sarcomas and its clinical applications. Int J Clin Exp Pathol 2010 1.15
14 Warfarin dosing and cytochrome P450 2C9 polymorphisms. Thromb Haemost 2004 1.12
15 Histologic characteristics of pancreatic intraepithelial neoplasia associated with different pancreatic lesions. Hum Pathol 2010 0.99
16 Copy number and gene expression differences between African American and Caucasian American prostate cancer. J Transl Med 2010 0.99
17 Benign hybrid perineurioma-schwannoma in the colon. A case report. Ann Diagn Pathol 2006 0.97
18 Microcarcinoids in large intestinal adenomas. Am J Surg Pathol 2006 0.95
19 Co-expression of XIAP and cyclin D1 complex correlates with a poor prognosis in patients with hepatocellular carcinoma. Am J Pathol 2012 0.93
20 The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia. BMC Gastroenterol 2010 0.93
21 Androgen receptor coactivator p44/Mep50 in breast cancer growth and invasion. J Cell Mol Med 2010 0.90
22 Isoprenylcysteine carboxylmethyltransferase deficiency exacerbates KRAS-driven pancreatic neoplasia via Notch suppression. J Clin Invest 2013 0.88
23 Expression and function of androgen receptor coactivator p44/Mep50/WDR77 in ovarian cancer. PLoS One 2011 0.87
24 Liver transplant for mixed capillary-cavernous hemangioma masquerading as hepatocellular carcinoma in a patient with hepatocellular carcinoma. Exp Clin Transplant 2011 0.86
25 Inverse relationship between cirrhosis and massive tumours in hepatocellular carcinoma. HPB (Oxford) 2012 0.83
26 Budd-Chiari syndrome in sarcoidosis involving liver. Liver Int 2008 0.82
27 Urethral adenocarcinoma associated with intestinal-type metaplasia, case report and literature review. Int J Clin Exp Pathol 2013 0.81
28 KRAS mutations are associated with specific morphologic features in colon cancer. J Clin Gastroenterol 2013 0.78
29 Distinct function of androgen receptor coactivator ARA70α and ARA70β in mammary gland development, and in breast cancer. Breast Cancer Res Treat 2010 0.77
30 Segmentation of microscopic images of small intestinal glands with directional 2-D filters. Anal Quant Cytol Histol 2005 0.77
31 Functional domains of androgen receptor coactivator p44/Mep50/WDR77and its interaction with Smad1. PLoS One 2013 0.77
32 Pancreatic carcinoma with multilineage (acinar, neuroendocrine, and ductal) differentiation. Int J Clin Exp Pathol 2009 0.77
33 Race and the molecular origins of breast cancer in Chinese women: breast cancer in Chinese women. Ann Surg Oncol 2012 0.76
34 A 48-year-old obese man with a 3 cm liver lesion and a history of hemochromatosis and lymphoma. Semin Liver Dis 2004 0.75
35 Is metastatic potential of breast cancer inherent or acquired? Lab Invest 2004 0.75